2-(Dimethylamino)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde, 97%, 250mg

2-Chlorobenzyl Bromide>98.0%(GC)5g

2-Ethyl-1-hexene, 95.0%, 5g

2,4-Dichloro-6-iodoquinazoline, 97%, 25g

1-((3aR,6S,7aS)-8,8-Dimethyl-2,2-dioxidohexahydro-1H-3a,6-methanobenzo[c]isothiazol-1-yl)ethanone, 95.0%, 250mg

4-(2-Oxo-pyrrolidin-1-yl)-benzaldehyde, 95.0%, 1g

N-Acetyl-L-glutamic acid, 95.0%, 5g

2-[(4S)-4,5-Dihydro-4-phenyl-2-oxazolyl]-6-(1,1-dimethylethyl)phenol, 1g

4-(1-Naphthyl)phenylboronic acid, 97.0%, 25g

Hexachloroplatinate de potassium (IV), min 99,9 %, pa, 500 mg, emballage en verre

4-BROMO-3-CHLORO-N-METHYL-2-NITROANILINE, 95%, 100mg

5-Bromo-2-methyl-3-nitroaniline, 95.0%, 10g

(2R,3S,4S,5S,6R)-2-(Hydroxymethyl)-6-(4-isothiocyanatophenoxy)tetrahydro-2H-pyran-3,4,5-triol, 97.0%, 10mg